Scienture Holdings, Inc. (SCNX): Shareholders' Equity
$70.12M
As of 2025-12-31
$64.10M
As of 2026-06-30
n/m
3-year compound annual growth
+51.9%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $70.12M | -11.3% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $79.07M | n/m | 2026-03-30, Balance as of period end |
| 2023-12-31 | $542.4K | -28.9% | 2025-03-26, Balance as of period end |
| 2022-12-31 | $763.1K | -79.8% | 2024-04-22, Balance as of period end |
| 2021-12-31 | $3.77M | -56.6% | 2023-03-27, Balance as of period end |
| 2020-12-31 | $8.68M | +109.6% | 2022-03-28, Balance as of period end |
| 2019-12-31 | $4.14M | +390.2% | 2021-03-29, Balance as of period end |
| 2018-12-31 | $844.7K | n/m | 2020-03-30, Balance as of period end |
| 2017-12-31 | -$311.9K | n/m | 2019-03-22, Balance as of period end |
| 2016-12-31 | -$1.15M | n/m | 2018-03-02, Balance as of period end |
| 2015-12-31 | $267.0K | -60.1% | 2016-03-28, Balance as of period end |
| 2014-12-31 | $668.4K | +410.8% | 2016-03-28, Balance as of period end |
| 2013-12-31 | $130.9K | n/a | 2015-03-23, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $70.12M | -11.3% |
| Medicinova Inc (MNOV) | 2025-12-31 | $41.59M | -20.8% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $5.59M | +2.9% |
| America Great Health (AAGH) | 2025-06-30 | -$5.66M | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $40.92M | -32.9% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $1.92M | -39.0% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $641.6K | -89.3% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$6.30M | n/m |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $62.30M | -53.5% |
Compare SCNX, MNOV, CANF, AAGH side by side · Screen every company in Pharmaceutical Preparations ↗